Author/Authors :
Eugene R Bleecker، نويسنده , , Dirkje S Postma، نويسنده , , Rachael M Lawrance، نويسنده , , Deborah A Meyers، نويسنده , , Helen J Ambrose، نويسنده , , Mitch Goldman، نويسنده ,
Abstract :
Background
New evidence has suggested that people with asthma who are homozygous for arginine at aminoacid 16 of the β2-adrenergic receptor (ADRB2) might not benefit from longacting β2-agonist therapy. We, therefore, investigated whether ADRB2 polymorphis
